1/160
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Small Molecule Intoxication Disorders
Disorders causing accumulation of metabolites/toxic conversion that causes toxicity to organs
Reduced Fasting Tolerance Disorders
Disorders that quickly cause a patient to be hypoglycemic, impacting organs that require high glucose levels
Mitochondrial Disorders
Disorders that impact the mitochondria, leading to energy deficiency
Complex Molecule Disorders
Disorders that impact the synthesis/processing/breakdown of complex molecules leading to slowly progressive symptoms
Categories of Metabolic Disorders - Small Molecule Intoxication
urea cycle disorders
organic acid disorders
aminoacidopathies
carbohydrate disorders
Categories of Metabolic Disorders - Reduced Fasting Intolerance
fatty acid oxidation disorders
glycogen storage disorders
Categories of Metabolic Disorders - Mitochondrial Disorders
Barth
Leigh
MELAS
MERRF
pyruvate carboxylase
Pearson
Kearns-Sayre
Categories of Metabolic Disorders - Complex Molecule Disorders
Gaucher
Krabbe
Smith-Lemli Opitz
Tay-Sachs
Mucopolysacchradioses
Peroxisomal disorders
Most common urea cycle disorder
OTC deficiency
Urea Cycle Disorders - Acute Symptoms
seizures
coma
brain edema
vomiting, confusion, slurred speech
death
Urea Cycle Disorders - Long Term Symptoms
cognitive impairment
variable ID
spastic quadriplegia
ataxia
Urea Cycle Disorders - Acute Treatment
no protein intake
IV ammonia scavengers
hemodialysis
Urea Cycle Disorders - Long Term Treatment
liver transplant (with severe UCDs)
protein restricted diet
potentially gene therapy
Proximal Urea Cycle Disorders
Taking place in mitochondria:
CPS, NAGS, OTC
LOW citrulline
Distal Urea Cycle Disorders
Taking place in cytosol:
ASS1 (citrullinemia), ASL, ARG
HIGH citrulline
CPS1 Deficiency
deficient carbamoyl phosphate synthetase 1
high ammonia, low citrulline
NAGS Deficiency
deficient N-acetylglutamate synthetase
high ammonia, low citrulline
OTC Deficiency
X-linked!
deficient ornithine transcarbamylase
high ammonia, high ornithine, high orotic acid, low citrulline
Citrullinemia (ASS1 Deficiency)
deficient arginosuccinic acid synthetase
HIGH citrulline levels
ASL Deficiency
deficient arginosuccinic acid lyase
high citrulline, high arginosuccinic acid
ARG Deficiency
deficient arginase
high arginine, usually no hyperammonemia
Organic Acid Disorders - General Symptoms
metabolic acidosis
hyperkalemia
compensatory hyperventialtion
changes in consciousness
flushed skin
headache
nausea
vomiting
Organic Acid Disorders - Biochemical Testing
urine organic acids
low pH
low CO2
Organic Acid Disorders - Treatment
low protein diet
metabolic formula
carnitine to bind organic acids
Isovaleric Acidemia Gene
IVD
Methylmalonic Acidemia Gene
MUT
Propionic Acidemia Genes
PCCA and PCCB
Isovaleric Acidemia - Clue
smelly feet odor
Galactosemias - General Symptoms
liver dysfunction
renal dysfunction
hypoglycemia
cataracts
lactic acidosis
hyperuricemia
GALT Deficiency
Gal-1-P deficiency
speech delay/DD, brain damage, cataracts, hepatomegaly, e-coli sepsis
GALE Deficiency
Psychomotor delays
GALK Deficiency
Cataracts only (maybe ID/FTT with poor diet control)
GALM Deficiency
Cataracts only
Duarte Allele
p. N314D
milder manifestation (attenuated protein)
Hereditary Fructose Intolerance - Gene/Protein
ALDOB
defective aldolase-B
Hereditary Fructose Intolerance - Symptoms
liver dysfunction
FTT
vomiting
hypoglycemia
Glutaric Aciduria Type 1 - Gene/Protein
GCDH
deficient glutaryl-CoA dehydrogenase enzyme activity
high lycine = toxic levels of glutaric acid
Glutaric Aciduria Type 1 - Symptoms
basal ganglia strokes, loss of motor control, encephalopathic crisis
stroke risk resolves after age 6
Glutaric Aciduria Type 1 - Biochemical Testing
urine organic acids (increased glutaric acid)
Glutaric Aciduria Type 1 - Treatment
limit protein
metabolic formula
toxin clearance with carnitine
Homocystinuria - Gene/Protein
CBS
defective cystathionine beta-synthase
problems with methionine synthesis causing toxic levels of homocysteine
Homocystinuria - Biochemical Testing
plasma amino acids (high methionine)
homocysteine levels
Homocystinuria - Symptoms
marfanoid habitus
strokes
ID
joint contractures
seizures
Homocystinuria - Treatment
low protein diet
metabolic formula
toxin clearance with betaine/vitamin B6
Non-Ketotic Hyperglycinemia - Gene/Protein
AMT, GLDC, GCSH
toxic levels of glycine
Non-Ketotic Hyperglycinemia - Biochemical Testing
plasma amino acids (high glycine levels)
Non-Ketotic Hyperglycinemia - Symptoms
intractable epilepsy
profound cognitive disability
no development of skills
Maple Syrup Urine Disease - Gene/Protein
BCKDHA, BCKDHB, DBT
defective branched chain amino acids
toxic isoleucine, leucine, and valine accumulation (leucine most toxic)
Maple Syrup Urine Disease - Biochemical Testing
plasma amino acids (isoleucine, leucine, and valine levels)
NBS (isoleucine/leucine ratios)
Maple Syrup Urine Disease - Symptoms
maple syrup smell in urine and earwax
brain swelling
DD
poor feeding
encephalopathy
seizures, coma, death
Maple Syrup Urine Disease - Treatment
limit protein
metabolic formula
Non-Ketotic Hyperglycinemia - Treatment
can’t limit precursors (most glycine made in body)
toxin clearance
Phenylketonuria - Gene/Protein
PAH
deficient phenylalanine hydroxylase
high Phe levels and tyrosine build-up
Phenylketonuria - Biochemical Testing
plasma amino acids (Phe levels)
NBS (mass spectrometry)
Phenylketonuria - Symptoms
ID
microcephaly
pale hair/skin
seizures
psych problems
mousy odor
Phenylketonuria - Treatment
limit protein
metabolic formula
toxin clearance (Kuvan, Palynziq)
Alkaptonuria - Gene/Protein
HGD
defective homogentisic 1,2 dioxygenase
impacts to tyrosine breakdown, toxic levels of homogentisic acid
Alkaptonuria - Biochemical Testing
urine organic acids (homogentisic acid levels)
Alkaptonuria - Symptoms
black urine (accumulation in eyes and ears)
joint inflammation
bone necrosis
aortic/mitral valve calcification
Alkaptonuria - Treatment
can’t limit precursors
nitisinone to clear toxins
Cystinuria - Gene/Protein
SLC3A1, SLC7A9
high cystine levels due to impaired reabsorption of cystine by renal tubules
Cystinuria - Biochemical Testing
urinary cystine excretion
Cystinuria - Symptoms
kidney stones
recurrent UTIs
chronic kidney disease
hypertension
Cystinosis - Gene/Protein
CTNS
defective cystinosin
cystine accumualtion in lysosomes
Cystinosis - Symptoms
infantile: renal Fanconi syndrome, poor growth, rickets, photophobia, end stage renal failure (10-12yrs)
juvenile: renal glomerular failure
adult/ocular: photophobia from corneal cystine crystal accumulation
Tyrosinemia - Gene/Protein
Type 1: FAH, defective 4-fumarylacteoacetase
Type 2: TAT, defective tyrosine transaminase
Toxic levels of succinylacetone
Tyrosinemia - Biochemical Testing
plasma amino acids (tyrosine and succinylacetone levels)
Tyrosinemia - Symptoms
Type 1: most severe, hepatosplenomegaly, acute liver failure, liver cancer risk
Type 2: keratosis palmoplantaris, ID, ocular and cutaneous findings
Tyrosinemia - Treatment
low protein
metabolic formula
toxin clearance with nitisinone (negates cancer risk)
Lesch-Nyhan - Gene/Protein
X-linked: HPRT1
deficient hypoxanthine-guanine phosphoribosyltransferase
overproduction of uric acid
Lesch-Nyhan - Symptoms
motor dysfunction (cerebral palsy-like)
ID
self-injurous behavior
hyperuricemia
renal failure
hyperuricemia only with XX
Fatty Acid Oxidation Disorders
disorders impacting the converting fatty acids into ketones for energy use in fasting states
primarily impact liver, muscles, heart, and brain
ALL present with hypoketotic hypoglycemia
all autosomal recessive
Fatty Acid Oxidation Disorders - Biochemical Testing
acylcarnitine profiles in urine/blood
urine organic acids (detect metabolic byproducts during crisis)
Primary Carnitine/Transporter Deficiency - Gene/Protein
SLC22A5
defective carnitine transporter, preventing transport of carnitine into mitochondria to process VLCFA
Primary Carnitine/Transporter Deficiency - Symptoms
cardiomyopathy
arrhythmias
Long QT
sudden death
hypoketotic hypoglycemia
Primary Carnitine/Transporter Deficiency - Molecular Testing
20% of PVs in SLC22A5 are intronic (c.-149G>A)
VLCAD Deficiency - Gene/Protein
ACADVL
inability to convert VLCFA to medium chain
VLCAD Deficiency - Symptoms
More severe
cardiomyopathy
exercise intolerance
seizures
chronic weakness
hepatomegaly
hypoketotic hypoglycemia
LCHAD/TFP Deficiency - Gene/Protein
HADHA/HADHB
part of trifunctional protein that catayzed beta-oxidation
LCHAD/TFP Deficiency - Symptoms
peripheral neuropathy
retinitis pigmentosa
cardiomyopathy
sudden death
seizures
exercise intolerance
hypoketotic hypoglycemia
MCAD Deficiency - Gene/Protein
ACADM
inability to break down medium chain fatty acids
Most common FAOD
MCAD Deficiency
MCAD Deficiency - Symptoms
actue liver dysfunction
hypoketotic hypoglycemia
coma/lethargy/sudden death
NO cardiomyopathy, rhabdomyolysis, or weakness
SCHAD Deficiency - Gene/Protein
HADH
inability to breakdown short chain fatty acids
SCHAD Deficiency - Symptoms
hyperinsulinism
hypoketotic hypoglycemia
acute liver dysfunction
coma/lethargy/sudden death
Glutaric Acidemia Type 2/MAD Deficiency - Gene/Protein
ETFA/ETFB/ETFDH
blocked delivery of electrons into ETC
Glutaric Acidemia Type 2/MAD Deficiency - Symptoms
MALFORMATIONS: dysmorphic facies, large cystic kidneys, genital anomalies
cardiomyopathy
exercise intolerance
seizures
encephalopathy
lethargy/coma/sudden death
hypoketotic hypoglycemia
Fatty Acid Oxidation Disorders - General Treatment
frequent feeds (can add cornstarch)
reduced fat intakes
use triheptanoin/MCT oil to bypass broken enzyme
Fatty Acid Oxidation Disorders - Acute Treatment
dextrose infusion
control hyperammonemia
diuresis
dialysis
Fatty Acid Oxidation Disorders - Severity
Most severe: VLCADD, LCHADD, and GA2
No cardiac involvement: MCADD and SCHAD
Glycogen Storage Disorders
disorders of glucose storage as glycogen in the liver or muscles
can either manifest with liver, muscle, or liver AND muscle complications
primarily autosomal recessive
GSD Type I (Von Gierke) - Gene/Protein
G6PC/SLC37A4
deficient glucose-6-phosphate
GSD Type I (Von Gierke) - Symptoms
liver GSD
hepatomegaly (with normal liver function)
severe hypoglycemia
truncal obesity
doll face
increased bleeding time
GSD Type Ib (Von Gierke) - Unique Symptoms
neutropenia
frequent and severe infections
GSD Type I (Von Gierke) - Treatment
frequent feeds
corn starch/glycosade
restrict to complex carbs
SGLT2 inhibitors to protect kidneys
liver transplant if severe
GSD Type II (Pompe Disease) - Gene/Protein
GAA
deficient alpha-glucosidase enzyme
alpha-glucosidase-maltase (adult-onset)
GSD Type II (Pompe Disease) - Symptoms
muscle GSD
infantile: cardiomyopathy with arrhythmias
proximal myopathy
motor delays
FTT
respiratory insufficiency
GSD Type II (Pompe Disease) - Treatment
enzyme replacement therapy available to break down glycogen and restore muscle function
GSD Type V (McArdle Disease) - Gene/Protein
PYGM
muscle glycogen phosphorylase deficiency
GSD Type V (McArdle Disease) - Symptoms
muscle GSD
hypoglycemia
exercise intolerance
rhabdomyolysis
second wind phenomenon